Baltimore, MDNCT05904548Now EnrollingIRB Ready

Atrial Flutter Typical Clinical Trial in Baltimore, MD

Access cutting-edge atrial flutter typical treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.

Sponsored by Imricor Medical Systems

Quick Self-Assessment

See if you qualify for this Baltimore location

Preparing your pre-screening questions…

Expert Care in Baltimore

Access atrial flutter typical specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related atrial flutter typical treatment provided free

Apply for This Baltimore Location

Check if you qualify for this atrial flutter typical clinical trial in Baltimore, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baltimore

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baltimore site if eligible
  4. 4Begin participation

About This Atrial Flutter Typical Study in Baltimore

The VISABL-AFL clinical investigation is a prospective, single-arm, multi-center, interventional, Investigational Device Exemption (IDE) trial. The primary objectives of VISABL-AFL are to assess the safety and efficacy of radiofrequency (RF) ablation of type-I atrial flutter performed with the Vision-MR Ablation Catheter 2.0 in the iCMR environment.

Sponsor: Imricor Medical Systems

Who Can Participate

Inclusion Criteria

Patient indicated for type I atrial flutter ablations with at least 1 documented episode of type I atrial flutter within 6 months (180 days) of enrollment
Patient 18 years and older

Exclusion Criteria

Contraindications for MRI procedures
Patients who cannot have anti-arrhythmic drugs (class I or class III) prescribed for the treatment of type I atrial flutter stopped on the day of the procedure
Previous CTI ablation procedures
Myocardial infarction within 60 days of enrollment
Current unstable angina
Cardiac surgery within 90 days of enrollment
Any cerebral ischemic event (including transient ischemic attacks) within 6 months (180 days) of enrollment
Thrombocytosis or thrombocytopenia
Contraindication to anticoagulation therapy
Currently documented intracardiac thrombus or myxoma
Implantation of permanent leads of an implantable device in or through the right atrium within 90 days of enrollment
Prosthetic valve through which the catheter must pass
Interatrial baffle or patch through which the catheter must pass
Moderate or severe tricuspid valve regurgitation or stenosis
Uncompensated congestive heart failure
Active systemic infection
Pregnancy or if subject plans to become pregnant during the trial
Uncontrolled hyperthyroidism
Any other significant uncontrolled or unstable medical condition
Enrollment in any concurrent study without Imricor written approval
Life expectancy of less than or equal to 2 years (730 days) per physician opinion

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baltimore?

Yes, this clinical trial (NCT05904548) has an active research site in Baltimore, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Atrial Flutter Typical Treatment Options in Baltimore, MD

If you're searching for atrial flutter typical treatment options in Baltimore, MD, this clinical trial (NCT05904548) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atrial flutter typical specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all atrial flutter typical clinical trials near you to find additional studies recruiting in your area.

More Follicular Lymphoma Trials in Baltimore, MD

See all follicular lymphoma clinical trials recruiting in Baltimore — not just this study.

Browse Follicular Lymphoma Trials in Baltimore →

Browse More Trials by Condition

Follicular Lymphoma TrialsInfluenza TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Baltimore?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baltimore, MD